Akeso, Inc. (HKG:9926)

Hong Kong · Delayed Price · Currency is HKD

117.90

-0.30 (-0.25%)

Jul 15, 2025, 10:44 AM HKT

Akeso Employees

Akeso had 3,035 employees as of December 31, 2024. The number of employees increased by 257 or 9.25% compared to the previous year.

Employees

3,035

Change (1Y)

257

Growth (1Y)

9.25%

Revenue / Employee

744.73K HKD

Profits / Employee

-180.41K HKD

Market Cap

106.09B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	3,035	257	9.25%
Dec 31, 2023	2,778	437	18.67%
Dec 31, 2022	2,341	476	25.52%
Dec 31, 2021	1,865	1,119	150.00%
Dec 31, 2020	746	356	91.28%
Dec 31, 2019	Pro	Pro	Pro

Related Stocks

Company Name	Employees
BeOne Medicines	11,000
Hansoh Pharmaceutical Group Company	8,989
Innovent Biologics	5,659
JD Health International	3,564
WuXi Biologics	12,575
Sino Biopharmaceutical	24,379
CSPC Pharmaceutical Group	21,400
Sichuan Kelun-Biotech Biopharmaceutical	1,837

Employee Rankings

Akeso News

6 weeks ago - Chinese biotech firm Akeso sinks after US partner’s cancer-drug setback - South China Morning Post
2 months ago - Why Is Summit Therapeutics Stock Trading Higher On Monday? - Benzinga
2 months ago - China’s Akeso, hailed as biotech’s ‘DeepSeek moment’, falls despite nod for cancer drug - South China Morning Post
2 months ago - What's Going On With Summit Therapeutics Stock On Friday? - Benzinga
2 months ago - Why Is Summit Therapeutics Stock Soaring On Wednesday? - Benzinga
3 months ago - Akeso (9926) Poised for Growth Despite Current Undervaluation - GuruFocus
3 months ago - Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain - Seeking Alpha
3 months ago - Why This Chinese Biotech Could Be Pharma's DeepSeek - Benzinga